Viatris (VTRS) Capital Expenditures (2020 - 2026)
Viatris (VTRS) recorded quarterly Capital Expenditures of $39.9 million in Q1 2026, down 79.69% quarter-over-quarter from $196.5 million in Q4 2025, and down 6.34% on a YoY basis from $42.6 million in Q1 2025.
Viatris (VTRS) Capital Expenditures (2020 - 2026) Analysis & Trends
Viatris' Capital Expenditures history runs 7 years deep, the most recent figure standing at $39.9 million for Q1 2026.
- In Q1 2026, Capital Expenditures fell 6.34% year-over-year to $39.9 million; the TTM figure through Mar 2026 stood at $376.1 million (up 17.97% YoY), while the FY2025 annual figure was $378.8 million, up 16.2% from the prior year.
- Capital Expenditures was $39.9 million for Q1 2026 at Viatris, down from $196.5 million in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $196.5 million in Q4 2025 to a low of $39.9 million in Q1 2026.
- Historically, Capital Expenditures has averaged $89.9 million across 5 years, with a median of $77.0 million in 2024.
- The sharpest annual moves came in 2023 and 2025: Capital Expenditures retreated 25.89% in 2023, then surged 39.96% in 2025.
- A 5-year view of Capital Expenditures shows it stood at $153.7 million in 2022, then advanced by 7.68% to $165.5 million in 2023, then fell by 15.17% to $140.4 million in 2024, then surged by 39.96% to $196.5 million in 2025, then slumped by 79.69% to $39.9 million in 2026.
- The last three Capital Expenditures figures came in at $39.9 million (Q1 2026), $196.5 million (Q4 2025), and $86.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 168.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 110.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 100.80 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 9.10 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 51.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 4.09 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 8.83 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 2.04 Mn |
| 10 | Viatris | - | - | 1.16 Bn | 39.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39.90 Mn |
| Mar 31, 2026 | 39.90 Mn |
| Dec 31, 2025 | 196.50 Mn |
| Dec 31, 2025 | 196.50 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Sep 30, 2025 | 86.80 Mn |
| Jun 30, 2025 | 52.90 Mn |
| Jun 30, 2025 | 52.90 Mn |
| Mar 31, 2025 | 42.60 Mn |
| Mar 31, 2025 | 42.60 Mn |
| Dec 31, 2024 | 140.40 Mn |
| Dec 31, 2024 | 140.40 Mn |
| Sep 30, 2024 | 77.00 Mn |
| Sep 30, 2024 | 77.00 Mn |
| Jun 30, 2024 | 58.80 Mn |
| Jun 30, 2024 | 58.80 Mn |
| Mar 31, 2024 | 49.80 Mn |
| Mar 31, 2024 | 49.80 Mn |
| Dec 31, 2023 | 165.50 Mn |
| Dec 31, 2023 | 165.50 Mn |